BANK OF AMERICA CORP /DE/ - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$183,509
-91.8%
42,479
-87.5%
0.00%
Q2 2023$2,233,515
-79.8%
338,925
-79.2%
0.00%
-100.0%
Q1 2023$11,075,441
+424.7%
1,631,140
+471.1%
0.00%
Q4 2022$2,110,667
-38.6%
285,611
-17.9%
0.00%
Q3 2022$3,438,000
-34.1%
347,925
-27.3%
0.00%
-100.0%
Q2 2022$5,219,000
+48.4%
478,709
+54.0%
0.00%
Q1 2022$3,516,000
-42.3%
310,830
-19.9%
0.00%
-100.0%
Q4 2021$6,089,000
+15.4%
388,050
+26.1%
0.00%0.0%
Q3 2021$5,277,000
-11.8%
307,776
+10.7%
0.00%0.0%
Q2 2021$5,981,000
+57.7%
278,063
+10.1%
0.00%
Q1 2021$3,792,000
+31.8%
252,512
+15.3%
0.00%
Q4 2020$2,878,000
+2.5%
218,963
-24.7%
0.00%
Q3 2020$2,809,000
+0.9%
290,768
+19.5%
0.00%
Q2 2020$2,785,000
+14.4%
243,401
+3.6%
0.00%
Q1 2020$2,435,000
-22.8%
234,959
+22.3%
0.00%
Q4 2019$3,154,000
+5.1%
192,180
-15.0%
0.00%
Q3 2019$3,001,000
-54.6%
226,009
-51.9%
0.00%
-100.0%
Q2 2019$6,617,000
-42.1%
469,598
-24.3%
0.00%
-50.0%
Q1 2019$11,420,000
+42.8%
620,650
+102.8%
0.00%
+100.0%
Q4 2018$7,995,000
+6.3%
306,012
-6.6%
0.00%0.0%
Q3 2018$7,520,000
+107.8%
327,630
+72.5%
0.00%0.0%
Q2 2018$3,619,000
+16.8%
189,936
+3.3%
0.00%0.0%
Q1 2018$3,098,000
+20.5%
183,896
+8.7%
0.00%
Q4 2017$2,572,000
-24.9%
169,155
-11.6%
0.00%
-100.0%
Q3 2017$3,425,000
+77.7%
191,284
+61.8%
0.00%
Q2 2017$1,927,000
+97.2%
118,250
+69.4%
0.00%
Q1 2017$977,000
-20.9%
69,815
-9.8%
0.00%
Q4 2016$1,235,000
+36.8%
77,376
+42.5%
0.00%
Q3 2016$903,000
+51.3%
54,305
+1.7%
0.00%
Q2 2016$597,000
+277.8%
53,406
+182.7%
0.00%
Q1 2016$158,000
-46.1%
18,892
-39.9%
0.00%
Q4 2015$293,000
-17.2%
31,460
+0.1%
0.00%
Q3 2015$354,000
-52.9%
31,416
-47.0%
0.00%
Q2 2015$752,000
-51.5%
59,268
-64.4%
0.00%
Q1 2015$1,550,000
+850.9%
166,507
+1367.9%
0.00%
Q4 2014$163,000
-11.4%
11,343
-36.4%
0.00%
Q3 2014$184,000
-31.6%
17,821
+7.1%
0.00%
Q2 2014$269,000
-71.7%
16,640
-71.6%
0.00%
Q1 2014$951,000
-39.3%
58,546
-53.6%
0.00%
-100.0%
Q4 2013$1,566,000
-45.0%
126,148
-51.5%
0.00%0.0%
Q3 2013$2,846,000
+32.4%
259,922
-2.3%
0.00%0.0%
Q2 2013$2,149,000265,9910.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders